Becton, Dickinson and Company (BDX)

NYSE: BDX · IEX Real-Time Price · USD
246.98
+1.81 (0.74%)
Mar 31, 2023, 12:32 PM EDT - Market open
0.74%
Market Cap 70.12B
Revenue (ttm) 19.00B
Net Income (ttm) 1.52B
Shares Out 283.90M
EPS (ttm) 5.31
PE Ratio 46.30
Forward PE 20.58
Dividend $3.56 (1.44%)
Ex-Dividend Date Mar 9, 2023
Volume 294,376
Open 246.49
Previous Close 245.17
Day's Range 244.25 - 247.23
52-Week Range 215.90 - 277.29
Beta 0.56
Analysts Buy
Price Target 279.48 (+13.16%)
Earnings Date May 4, 2023

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devic... [Read more]

Sector Healthcare
IPO Date Apr 23, 1962
Employees 77,000
Stock Exchange NYSE
Ticker Symbol BDX
Full Company Profile

Financial Performance

In 2022, BDX's revenue was $18.87 billion, a decrease of -1.36% compared to the previous year's $19.13 billion. Earnings were $1.69 billion, a decrease of -15.63%.

Financial Statements

Analyst Forecast

According to 22 analysts, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $279.48, which is an increase of 13.16% from the latest price.

Price Target
$279.48
(13.16% upside)
Analyst Consensus: Buy
Stock Forecasts

News

BDX or WST: Which Is the Better Value Stock Right Now?

BDX vs. WST: Which Stock Is the Better Value Option?

Other symbols: WST
1 day ago - Zacks Investment Research

7 Dividend Aristocrats to Buy for Consistent Income Growth

I'd argue there's never been a better time to consider investing in dividend aristocrats. Volatility remains very high in the overall market, with a destabilized banking sector.

Other symbols: ALBJNJMMMDOVMKCSJM
2 days ago - InvestorPlace

2 Unique Dividend Aristocrats to Diversify the Portfolio

Here are two Dividend Aristocrats that are top-rated Zacks stocks at the moment and can offer unique exposure and diversification to investors' portfolios.

Other symbols: LIN
1 week ago - Zacks Investment Research

BD's (BDX) New FDA Approval to Improve Vaginitis Testing

BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.

2 weeks ago - Zacks Investment Research

BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis

BD Vaginal Panel on BD COR™ System Tests for Multiple Common Types of Vaginitis Using Only One Swab, One Test FRANKLIN LAKES, N.J. , March 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (...

2 weeks ago - PRNewsWire

Healthcare Stocks With at Least 30 Years of Dividend Increases

While it is not the only factor to consider, the annual dividend can solidify whether a stock will benefit you financially. And among the many industry sectors to invest in, healthcare can be one of t...

Other symbols: ABBVABTCAHJNJMDTROPWST
2 weeks ago - MarketBeat

3 Stocks to Buy for Consistent Dividend Growth

Some of these companies have been around for over 100 years and have seen all imaginable economic environments

Other symbols: AFLHSY
2 weeks ago - Zacks Investment Research

Three Reasons to Add BD (BDX) Stock to Your Portfolio Now

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.

3 weeks ago - Zacks Investment Research

BD (BDX) Boosts Molecular Diagnostics Portfolio With New Tests

Recent developments in the Molecular Diagnostics space have been aiding key MedTech players like BD (BDX) to boost their business.

3 weeks ago - Zacks Investment Research

BDX or ALGN: Which Is the Better Value Stock Right Now?

BDX vs. ALGN: Which Stock Is the Better Value Option?

Other symbols: ALGN
3 weeks ago - Zacks Investment Research

BD to Present at Barclays Global Healthcare Conference

FRANKLIN LAKES, N.J. , March 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays G...

1 month ago - PRNewsWire

BD's (BDX) New FDA Approval to Improve Cervical Cancer Testing

BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of cervical cancer.

1 month ago - Zacks Investment Research

The 7 Best Dividend Growth Stocks for Long-Term Investors

When faced with myriad market ambiguities, investors may be well served to target the best dividend growth stocks to buy. In many ways, this investment category represents the best of both worlds.

Other symbols: DVNFANGKIMKOPMSYY
1 month ago - InvestorPlace

BD to Present at Cowen 43rd Annual Healthcare Conference

FRANKLIN LAKES, N.J. , Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Cowen 43rd...

1 month ago - PRNewsWire

BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test

Expands Access to BD HPV Test that More Precisely Identifies Patients' Risk for Cervical Cancer FRANKLIN LAKES, N.J. , Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a l...

1 month ago - PRNewsWire

BD Named as One of America's Best Large Employers

FRANKLIN LAKES, N.J. , Feb. 15, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the company has been named to America's...

1 month ago - PRNewsWire

BD's (BDX) Latest Combination Test Receives the FDA's EUA

BD's (BDX) new combination test is likely to significantly aid clinicians in treating patients in the current and future respiratory virus seasons.

1 month ago - Zacks Investment Research

BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test

Single Test on BD MAX™ Molecular Diagnostic System Identifies and Differentiates Multiple Respiratory Infectious Diseases FRANKLIN LAKES, N.J. , Feb. 8, 2023 /PRNewswire/ -- BD (Becton, Dickinson and ...

1 month ago - PRNewsWire

BDX vs. WST: Which Stock Is the Better Value Option?

BDX vs. WST: Which Stock Is the Better Value Option?

Other symbols: WST
1 month ago - Zacks Investment Research

BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery

New BD Rhapsody™ HT Xpress System and Other Innovations to be Unveiled at AGBT, Enhancing an End-To-End Single-Cell Multiomics Offering FRANKLIN LAKES, N.J. , Feb. 3, 2023 /PRNewswire/ -- BD (Becton, ...

2 months ago - PRNewsWire

BD (BDX) Q1 Earnings and Revenues Beat Estimates, Margins Down

The majority of BD's (BDX) core units witness strong revenue growth in the fiscal first quarter.

2 months ago - Zacks Investment Research

Becton Dickinson (BDX) Tops Q1 Earnings and Revenue Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 11.61% and 0.85%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

BD Reports First Quarter Fiscal 2023 Financial Results

Execution of BD 2025 Strategy Delivering Consistent and Durable Performance Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basis Revenue from base business...

2 months ago - PRNewsWire

MedTech Stocks' Earnings to Watch on Feb 2: BDX, DGX & CNMD

Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how BDX, DGX and CNMD are likely to fare this time.

Other symbols: CNMDDGX
2 months ago - Zacks Investment Research

Should You Buy Becton Dickinson (BDX) Ahead of Earnings?

Becton Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 months ago - Zacks Investment Research